I agree.

Also, at these low prices I plan on atleast doubling my money on recent purchases. imo Good luck everyone!

Well said Mike. Let's move forward and see what happens.

No problem, and thank you again for helping with the board. Good luck.

Tom

No problem, Geeterhoolagan did not reply to me, so I asked Mike for his help.

Got a response from Nik:

Tom

Please see below for top line competitor info as requested.


Regards


Nik



Competitor Companies Growth and PPS





Competitor A, the largest, oldest, but slowest growing corporation because of their inability to quickly convert, has still increased revenues by 7% over the last three years. Currently $9.84 a share.



Through only the last four quarters, Competitor B has increased revenues by a whopping 28%.

Currently $2.24 a share.



Competitor C has increased year-over-year revenues for the past 4 years by over 10 million each year. It has increased revenues by 14% compared to three years previous. Currently $34.76 a share.



Competitor D has also increased year-over-year revenues for the past 4 years. It has increased revenues by 22% compared to three years previous.

Currently $8.78 a share.





*prices taken as of April 30, 2007

Not yet Bob, I will post as soon as I hear.

I asked something similar Lem, but no response as of yet. I will post as soon as I get one. I think all questions will be answered next week.

I want a dime by end of week.

Sorry... the bid/ask is .03/.04 Lots of activity.

Huge volume.... and we are up the ask/bid are climbing. two large purchases of 350,000!!

That could be. I'm looking forward to next week.

Sorry Pick, I just noticed that you posted that.

I just pulled this off of the google message board from Nik :

Dear All

I thought I would post following several enquiries received yesterday
following the acqusition announcement. I can confirm that there is no
reverse split planned concurrent with this activity.


The Company has no plans to action a reverse split. It is the view of
the Board that a reverse split is not necessary with this acqusition.
In the sector occupied by the new acquisition there are currently a
very small number of publically traded companies. These companies
offer an average pps of $7.67 as of close of play yesterday.


Futher details, including the identity of the new acquisition will be
announced next week.


I hope this answers the concerns raised.


Best Regards


Nik Ellwood
Medify Solutions Limited

You got it Dog!

Cool, good luck with your plan as well! Maybe someday we'll meet in the middle.

Good luck with that Dog!

Clancy, I put that exact question out to JB for any type of response. Basically pleaded.. His response :


Tjak, Just thought I would let you know that I have checked out the Medify acquisition.



For those that will undoubtedly ask, it is for real, it is a stock purchase and there are absolutely no plans for a reverse split.



The reason for this is that the company is using the Medify Pink Sheet status as a fast track to Junior NASDAQ which means that to satisfy the rules, the emergent company needs to have a market cap in excess of $300m. It is anticipated that the pps after the announcement and revenue projections are made public will settle 2 to 3 weeks after the launch at around $5 which will satisfy the market cap requirement. Then it is only a matter of holding the pps high enough, I believe 30 days, then the company will be on for a move out of the pinks. Quite a subtle plan, sensible and very effective and will immediately address the issues the company has faced on the pinks.





What is interesting is that the acquired company operates in a market that is worth $57bn annually in the US and there are only 9 other companies of the like floated. The average pps for these companies is $8. So if they plan on the pps settling after the initial euphoria at around $5, we should expect in the initial rush next week to put the pps at a much higher price to begin with.





So I wish you well and hopefully Medify will now have the steam to progress without 504’sss, borrowing or additional investment.

I hear you Solid! The PR states that this will happen next week. It takes a strong position to rapidly reverse the current undervaluation of equity in a company. I see this as an opportunity. Some won't but I do. At this stage in the game to me it's a small risk for a huge upside.

I did! Good luck. I think this is huge for the PPS going forward. We won't be in this position next week. imo

News out on site: http://www.medifysolutions.com/newsarticle.php?articleid=76

Positive news to me. Medifyremote is going to make money, this seems like it will help fund the cause. This is good news for the longs. Take the PPS higher!!! Good luck all.

Quarterly report is out http://www.pinksheets.com/pdfservlet?id=10519

Bob that's probably because I didn't either. Maybe you will get it when the quarterly comes out. Have a nice day on the bus.

Not since the last response I posted.

Long time holder, also waiting for the release. Can't wait for that one day! Good luck.

Good luck this week everyone!! I think this week we should here big news!! Have a great week.

Oh, OK then. My bad.

Clancy don't shoot the messenger. Just reporting what happened when I called. You can call if you like.

I called, but got the voicemail of the secretary. When something comes up I will post it. Back to work for now.

Good luck.

Yes by email.

No I don't. JB has not responded to the last questions, so I think it is wait and see. Good luck.

Sure did, among other questions but no response. Good luck.

I've sent every question. I'm sure he answered it. If not repost it and I will send it again, but relax bob. With this anger maybe you shouldn't drive the yellow bus?

response from JB:

All of those are pertinent propositions and I will put them to Ian. The
stock is restricted under a private arrangement which under the terms must
remain private. But as the stock has been available for me to sell for some
time and not one share has been sold, the position is of no threat to the
share holders nor the company.

My understanding is that this is an all stock transaction. The result is
that the parent company will have immediate revenues and two significant
positions under it's charge. So that must be good for all of us.

response to your question:

All the stock is restricted and subject to certain conditions.

Yes if required I would utilise the stock.

Not sure what exactly the question is. Are you asking me would I "buy"
Medify utilising my stock to fund to be reimbursed in the future or are you
asking whether I would provide some of the stock to ensure the deal goes
through? Either way I am open to suggestions and have already offered some
suggestions. Now I could fund Medify in a deal that allowed the acquisition
to go through and I fund Medify allowing a fresh start to the acquisition
and the share holders and then handing Medify back once it is profitable. So
I take the risk and the cost and share holders still own? That is a deal I
would welcome but Ian may have all the bases covered.

Pick,

Put together a question, and I will forward it.

thanks

Response from JB:

Not sure I get the logic. In any merger or acquisition the ultimate aim is to improve the return and position of the company and the share holders. However one of the downsides is that everyone gets diluted. But if the upside is greater than the effects of the dilution, then who cares. You are also assuming a par deal as opposed to a stock for valuation deal. Maybe it’s a valuation deal which would be less dilution and nowhere near the impact of the reverse. I am only speculating and we will all find out in the next few days.

response to your question:



One would think so but hope not. I would think your observation is correct and the company practically would buy Medify but as Medify is the incumbent Pink sheet listed entity, then the legal process is the other way around with the new company emerging.



Now maybe you’re onto something here. If the company is buying Medify through a reverse merger and the surviving entity becomes the new Pink Sheet listed company, then maybe this will allow Medify the time to breathe whilst it pushes to revenue. Also, the surviving and now new lead entity has a free run on it’s listing. It’s revenue and PR will lead the news stories and with revenue being published, as everyone has said, will drive the pps up. So in real terms, the investors would in this scenario, keep hold of Medify for long term investment, whilst now owning stock in a company that has revenue and history. Now that would be sweet and I would be interested in any thoughts.



To be honest that makes perfect sense. Medify is kept going whilst it develops in-line with the NHS, and the parent company now has a new operational subsidiary which, and thus the share holders now gain shares in a profitable company. Maybe Ian has come up with a perfect scenario that we can all benefit from, address the past, gives the company the immediate chance of success and I don’t; think anyone would complain if Medify progressed to revenue without burdening the parent company (pinks listed entity) and they have shares that have a real chance of climbing?

Good thought. That would be fine with me.

response to your question:



Medify has received the READ Codes and they are with the development team.

Medify now has everything it needs to go to the market with Liverpool.

Everything is working fine and is in final testing.

The only thing missing is the cash to run the business hence the acquisition which provides just that and additional revenue immediately.



211 – the NASD want a legal opinion to confirm that various transactions occurred prior to Medify’s reverse. These were transactions with Securiteyes and Blog8 months before the reverse. Obviously Medify does not have all the docs so this is just corporate diligence and is legal requirement.



eSource have agreed to the deal with the docs to be sent by Friday of this week for legal review and signing. However, with the acquisition just about to occur, I believe Ian is in a position of choice and it would be nice to get one signed off as I think it is now down to an either or as the vehicle for funding.



Privately, I have my own theories on what is going on and I am very happy with what I suspect as there is a huge upside immediately to all share holders.



What if the “day to day management” of Medify, maybe under licence and the historical financial burden of running the company is passed on to eSource, maybe on a royalty agreement and at the same time, Medify acquires an existing profitable business in a high value market. What that would mean is that the historical financial burden goes away, no 504’s, and the Medify share holders immediately benefit form a profitable new company with immediate inward investment, which by definition means the pps rises exponentially with the new investors coming in?



Just a theory but it might work and if it does then the $8 pps is definitely achievable.

Response to your question:

Yes you are correct that there are a lot of pinkies out there but they
usually cost sometimes up to $250K. Also the fact that Medify has an
exisiting Pinky operation is a bonus.

Now yes the NHS cntrcacts are there, as is Vodafone and TPP, but you are
looking at 2 - 3 motnhs rea;sitically before the rveneues kick in. That
means 3-4 months of 504 to fund the company which everyone criticises.
Also assuming no more delays, but what if there are deays, then maybe
5-6 months of 504's and so on. Ian would be persecuted, so what are the
options.


If the revenue is there to support the develoemnt and lead time to the
market then it makes perfect sense. To be honest, having been in the hot
seat and received the hundreds of e-maisl on the 504 situation, I am not
surprised Ian has gone down this route. He is concentrting on the
business and dleivering the business which will take a few more months
before the revenue. He is looking at htinsg not from the personal
invetor view but form the long term success of the compnay and investpor
psotion, which is good. The only controled vehicle left to run the
business, 504's or borrowing money, is constantly criticised, thus he
has explored other options. If it works, then we all win.

My view is very simple, any process used to raise the cash needed to
take this to the market and avoiding 504's is a good decision. Let's
hope it pans out.